170 related articles for article (PubMed ID: 2554342)
21. Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.
Jentsch JD; Verrico CD; Le D; Roth RH
Neurosci Lett; 1998 May; 246(3):169-72. PubMed ID: 9792619
[TBL] [Abstract][Full Text] [Related]
22. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat.
Santiago M; Westerink BH
Neurochem Int; 1992 Mar; 20 Suppl():107S-110S. PubMed ID: 1365406
[TBL] [Abstract][Full Text] [Related]
24. Aged Fischer 344 rats exhibit altered locomotion in the absence of decreased locomotor activity: exacerbation by nomifensine.
Stanford JA; Vorontsova E; Surgener SP; Gerhardt GA; Fowler SC
Neurosci Lett; 2002 Nov; 333(3):195-8. PubMed ID: 12429381
[TBL] [Abstract][Full Text] [Related]
25. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
Umeda Y; Sumi T
Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
[TBL] [Abstract][Full Text] [Related]
26. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms.
Gandolfi O; Rimondini R; Dall'Olio R
Neuropharmacology; 1992 Nov; 31(11):1111-4. PubMed ID: 1335556
[TBL] [Abstract][Full Text] [Related]
27. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.
Kerkerian-Le Goff L; Forni C; Samuel D; Bloc A; Dusticier N; Nieoullon A
Brain Res Bull; 1992 Feb; 28(2):187-93. PubMed ID: 1596740
[TBL] [Abstract][Full Text] [Related]
28. Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.
Malone DT; Taylor DA
Br J Pharmacol; 1999 Sep; 128(1):21-6. PubMed ID: 10498830
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
Ponzio F; Achilli G; Perego C; Algeri S
Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
[TBL] [Abstract][Full Text] [Related]
30. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
Jackson D; Abercrombie ED; Zigmond MJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
[TBL] [Abstract][Full Text] [Related]
31. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices.
Zelles T; Chernaeva L; Baranyi M; Déri Z; Adam-Vizi V; Vizi ES
J Neurosci Res; 1995 Oct; 42(2):242-51. PubMed ID: 8568925
[TBL] [Abstract][Full Text] [Related]
32. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
Kaneno S; Watanabe A; Takahashi R
Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
[TBL] [Abstract][Full Text] [Related]
33. The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.
Janhunen S; Mielikäinen P; Paldánius P; Tuominen RK; Ahtee L; Kaakkola S
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):480-91. PubMed ID: 16012872
[TBL] [Abstract][Full Text] [Related]
34. Naloxone elicits dose-dependent changes in alcohol-induced increases in endogenous dopamine release from rat striatum.
Holman RB; Snape BM; Widdowson PS
Alcohol Alcohol Suppl; 1987; 1():737-41. PubMed ID: 3426755
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.
Nishijima K; Kashiwa A; Hashimoto A; Iwama H; Umino A; Nishikawa T
Synapse; 1996 Apr; 22(4):304-12. PubMed ID: 8867025
[TBL] [Abstract][Full Text] [Related]
36. Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo.
Kanzaki A; Akiyama K; Otsuki S
Brain Res; 1992 Jan; 569(2):181-8. PubMed ID: 1371707
[TBL] [Abstract][Full Text] [Related]
37. Dopaminergic toxicity of the herbicide atrazine in rat striatal slices.
Filipov NM; Stewart MA; Carr RL; Sistrunk SC
Toxicology; 2007 Mar; 232(1-2):68-78. PubMed ID: 17218051
[TBL] [Abstract][Full Text] [Related]
38. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
39. Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature.
Crutchfield KC; Dluzen DE
Neurotox Res; 2006 Jan; 9(1):15-21. PubMed ID: 16464748
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of [3H]dopamine release and its [3H]metabolites in rat striatum by nicotinic drugs.
Sakurai Y; Takano Y; Kohjimoto Y; Honda K; Kamiya HO
Brain Res; 1982 Jun; 242(1):99-106. PubMed ID: 6179571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
